When 60,000 attendees descend on Tokyo Big Sight April 27–29, the headline numbers are hard to ignore: 750 startup exhibitors, 151 sessions, city leaders from 49 countries. But the stat that tells you what kind of event this actually is? It's 10,000 facilitated business meetings — brokered, booked, and tracked before most attendees even land.
A lot of AI startups exist partly because the foundation models haven't expanded into their category yet. As many jokingly acknowledge, that won't last forever.
In recent months, the company announced an agreement with Amazon Web Services to use Cerebras chips in Amazon data centers, as well as a deal with OpenAI reportedly worth more than $10 billion.
The gap between AI insiders and everyone else is widening, and the spending, suspicion, and even new vocabulary are starting to show it. While OpenAI is busy buying up everything from finance apps to talk shows, a certain shoe company just rebranded as an AI infrastructure play, and Anthropic unveiled a model it says is too powerful to release publicly …but apparently not too […]
Anthony Ha, Theresa Loconsolo, Kirsten Korosec, Sean O'Kane
The gap between AI insiders and everyone else is widening, and the spending, suspicion, and even new vocabulary are starting to show it. While OpenAI is busy buying up everything from finance apps to talk shows, a certain shoe company just rebranded as an AI infrastructure play, and Anthropic unveiled a model it says is too powerful to release publicly …but apparently not too […]
Users are fed up with misinformation and AI slop cluttering their feeds. SaySo is a new short-form video app that delivers news from vetted creators and journalists.
When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]